ArticleThe Journal of biological chemistry2026
High-density lipoprotein mediates silica nanoparticle recognition by the multiligand receptor SR-B1.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scavenger receptor class B type 1 (SR-B1), best known as a high-density lipoprotein (HDL) receptor, is now recognized as a multi-ligand membrane receptor. In addition to HDL, SR-B1 binds low-density lipoprotein (LDL), hepatitis C virus, Gram-positive and Gram-negative bacteria, and inorganic silica particles. However, the mechanisms by which SR-B1 recognizes diverse ligands remain unclear. We previously reported that a basic amino acid cluster consisting of K151, K156, and K395 at the extracellular apex of SR-B1 is essential for charge-dependent binding to silica and is distinct from the known HDL-binding site. In this study, homology modeling of SR-B1 revealed the HDL-binding site is oriented toward the basic cluster. Site-directed mutagenesis demonstrated that this basic cluster is required for HDL and, to a lesser extent, LDL binding, which in turn promotes binding to silica nanoparticles. The selective binding of SR-B1 to silica nanoparticles, but not to titanium dioxide nanoparticles, latex nanoparticles, monosodium urate crystals, or multiwalled carbon nanotubes, depends on specific HDL-silica or LDL-silica interactions. These findings suggest that HDL, and potentially LDL, may underlie SR-B1's function as a mutiligand membrane receptor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.